ID
24533
Description
Study ID: 100470 Clinical Study ID: SCO100470 Study Title: A multicentre, randomised, double-blind, parallel group, 24 week study to compare the effect of salmeterol/fluticasone propionate combination product 50/250mcg, with salmeterol 50mcg both delivered twice daily via DISKUS®/ACCUHALER® inhaler on lung function and dyspnoea in subjects with Chronic Obstructive Pulmonary Disease (COPD). Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: N/A Sponsor:GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: fluticasone propionate/salmeterol Trade Name: Serevent Study Indication: Pulmonary Disease, Chronic Obstructive
Keywords
Versions (2)
- 8/5/17 8/5/17 -
- 8/8/17 8/8/17 -
Copyright Holder
GlaxoSmithKline
Uploaded on
August 5, 2017
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
follow-up salmeterol/fluticasone propionate combination compared to salmeterol on COPD 100470
follow-up salmeterol/fluticasone propionate combination compared to salmeterol on COPD 100470
Description
VITAL SIGNS
Alias
- UMLS CUI-1
- C0518766
Description
CENTRAL LABORATORY - BLOOD
Alias
- UMLS CUI-1
- C0018941
Similar models
follow-up salmeterol/fluticasone propionate combination compared to salmeterol on COPD 100470
C0582103 (UMLS CUI-2)
C3887511 (UMLS CUI [1,2])
C0563454 (UMLS CUI [1,2])
C0563454 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,3])